CA2555509A1 - Nouvelles sequences d'acides amines et de nucleotides, et dosages et methodes d'utilisation connexes pour le diagnostic du cancer du poumon - Google Patents

Nouvelles sequences d'acides amines et de nucleotides, et dosages et methodes d'utilisation connexes pour le diagnostic du cancer du poumon Download PDF

Info

Publication number
CA2555509A1
CA2555509A1 CA002555509A CA2555509A CA2555509A1 CA 2555509 A1 CA2555509 A1 CA 2555509A1 CA 002555509 A CA002555509 A CA 002555509A CA 2555509 A CA2555509 A CA 2555509A CA 2555509 A1 CA2555509 A1 CA 2555509A1
Authority
CA
Canada
Prior art keywords
pea
amino acid
amino acids
acid sequence
homologous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002555509A
Other languages
English (en)
Inventor
Sarah Pollock
Zurit Levine
Amit Novik
Dvir Dahary
Rotem Sorek
Amir Toporik
Shirley Sameah-Greenwald
Osnat Sella-Tavor
Alexander Diber
Gad S. Cojocaru
Michal Ayalon-Soffer
Shira Walach
Pinchas Akiva
Naomi Keren
Ronen Shemesh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Compugen USA Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from US11/051,720 external-priority patent/US7569662B2/en
Publication of CA2555509A1 publication Critical patent/CA2555509A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention se rapporte à de nouveaux marqueurs sensibles et précis du cancer du poumon. Ces marqueurs sont particulièrement surexprimés dans le cancer du poumon, en comparaison au tissu pulmonaire normal. La mesure de ces marqueurs, seuls ou associés, dans des échantillons de patients, fournit des informations que le diagnosticien peut mettre en corrélation avec un diagnostic probable du cancer du poumon. Les marqueurs selon l'invention, seuls ou combinés, montrent un degré élevé de détection différentielle entre le cancer du poumon et des états non cancéreux.
CA002555509A 2004-01-27 2005-01-27 Nouvelles sequences d'acides amines et de nucleotides, et dosages et methodes d'utilisation connexes pour le diagnostic du cancer du poumon Abandoned CA2555509A1 (fr)

Applications Claiming Priority (63)

Application Number Priority Date Filing Date Title
US53912804P 2004-01-27 2004-01-27
US53912904P 2004-01-27 2004-01-27
US60/539,129 2004-01-27
US60/539,128 2004-01-27
US58981504P 2004-07-22 2004-07-22
US60/589,815 2004-07-22
US60730704P 2004-09-07 2004-09-07
US60/607,307 2004-09-07
US62087404P 2004-10-22 2004-10-22
US62092404P 2004-10-22 2004-10-22
US62065604P 2004-10-22 2004-10-22
US62067704P 2004-10-22 2004-10-22
US62097504P 2004-10-22 2004-10-22
US62097404P 2004-10-22 2004-10-22
US62091604P 2004-10-22 2004-10-22
US62100404P 2004-10-22 2004-10-22
US62086804P 2004-10-22 2004-10-22
US62091704P 2004-10-22 2004-10-22
US62085304P 2004-10-22 2004-10-22
US62091804P 2004-10-22 2004-10-22
US60/620,974 2004-10-22
US60/620,917 2004-10-22
US60/621,004 2004-10-22
US60/620,924 2004-10-22
US60/620,868 2004-10-22
US60/620,874 2004-10-22
US60/620,656 2004-10-22
US60/620,975 2004-10-22
US60/620,677 2004-10-22
US60/620,853 2004-10-22
US60/620,918 2004-10-22
US60/620,916 2004-10-22
US62113104P 2004-10-25 2004-10-25
US62105304P 2004-10-25 2004-10-25
US60/621,053 2004-10-25
US60/621,131 2004-10-25
US62817804P 2004-11-17 2004-11-17
US62814504P 2004-11-17 2004-11-17
US62825104P 2004-11-17 2004-11-17
US62811204P 2004-11-17 2004-11-17
US62811104P 2004-11-17 2004-11-17
US62818904P 2004-11-17 2004-11-17
US62816704P 2004-11-17 2004-11-17
US62813404P 2004-11-17 2004-11-17
US62810104P 2004-11-17 2004-11-17
US62815604P 2004-11-17 2004-11-17
US62812304P 2004-11-17 2004-11-17
US60/628,111 2004-11-17
US60/628,134 2004-11-17
US60/628,178 2004-11-17
US60/628,251 2004-11-17
US60/628,101 2004-11-17
US60/628,123 2004-11-17
US60/628,189 2004-11-17
US60/628,112 2004-11-17
US60/628,145 2004-11-17
US60/628,167 2004-11-17
US60/628,156 2004-11-17
US63407504P 2004-12-08 2004-12-08
US60/634,075 2004-12-08
US11/051,720 2005-01-27
PCT/IB2005/004037 WO2006131783A2 (fr) 2004-01-27 2005-01-27 Nouvelles sequences d'aminoacides et de nucleotides, et dosages et methodes d'utilisation afferentes dans le diagnostic du cancer du poumon
US11/051,720 US7569662B2 (en) 2004-01-27 2005-01-27 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
CA2555509A1 true CA2555509A1 (fr) 2005-07-27

Family

ID=37450522

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002555509A Abandoned CA2555509A1 (fr) 2004-01-27 2005-01-27 Nouvelles sequences d'acides amines et de nucleotides, et dosages et methodes d'utilisation connexes pour le diagnostic du cancer du poumon

Country Status (5)

Country Link
EP (1) EP1774046A4 (fr)
JP (1) JP2008507261A (fr)
AU (1) AU2005320352A1 (fr)
CA (1) CA2555509A1 (fr)
WO (1) WO2006131783A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947436B2 (en) 2004-12-13 2011-05-24 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
AU2009333580B2 (en) 2008-12-09 2016-07-07 Genentech, Inc. Anti-PD-L1 antibodies and their use to enhance T-cell function
KR101403019B1 (ko) 2013-02-25 2014-06-03 서울대학교산학협력단 폐암 진단용 마커
CN114804550B (zh) * 2022-06-10 2023-06-02 安徽新宇环保科技股份有限公司 一种基于神经网络模型的污水处理调控系统
CN115894942B (zh) * 2022-11-07 2024-01-12 同济大学 聚己内酯修饰的超支化梳型聚赖氨酸及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8623198A (en) * 1997-08-14 1999-03-08 Novo Nordisk A/S Antimicrobial composition containing a haloperoxidase, a hydrogen peroxide source, a halide source and an ammonium source
US20030170255A1 (en) * 1999-06-30 2003-09-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2002004514A2 (fr) * 2000-07-11 2002-01-17 Corixa Corporation Compositions et procedes pour le traitement et le diagnostic du cancer du poumon
CA2444691A1 (fr) * 2001-04-18 2002-10-31 Protein Design Labs, Inc. Procedes de diagnostic du cancer du poumon, compositions et procedes de criblage de modulateurs du cancer du poumon
WO2003004989A2 (fr) * 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, trousses, et procedes d'identification, d'evaluation, de prevention, et de therapie pour le cancer du sein
AU2003234623A1 (en) * 2002-05-16 2003-12-02 Euro-Celtique, S.A. Use of gastrin releasing peptide (grp) and its receptor in cancer screening

Also Published As

Publication number Publication date
AU2005320352A1 (en) 2006-08-31
EP1774046A4 (fr) 2010-09-15
AU2005320352A2 (en) 2006-08-31
WO2006131783A2 (fr) 2006-12-14
EP1774046A2 (fr) 2007-04-18
JP2008507261A (ja) 2008-03-13
AU2005320352A8 (en) 2009-04-30
WO2006131783A3 (fr) 2009-08-27

Similar Documents

Publication Publication Date Title
US7368548B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer
US7569662B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
US7553948B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
DK2456889T3 (en) Markers of endometrial cancer
AU2005207886A1 (en) Novel brain natriuretic peptide variants and methods of use thereof
US20060014166A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis
US20100068736A1 (en) Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer
US7345142B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
US20090215046A1 (en) Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer
US7332569B2 (en) Brain natriuretic peptide spliced variant
US7528243B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
US7714100B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
US20060263786A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
WO2010061393A1 (fr) Séquences d'acides aminés et de nucléotides de variants de he4 et leurs procédés d'utilisation
CA2555509A1 (fr) Nouvelles sequences d'acides amines et de nucleotides, et dosages et methodes d'utilisation connexes pour le diagnostic du cancer du poumon
WO2006054297A2 (fr) Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et leurs procedes d'utilisation pour le diagnostic
CA2554703A1 (fr) Expression differentielle de marqueurs dans le cancer de l'ovaire
US7906635B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
AU2005207882A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
WO2006043271A1 (fr) Nouvelles sequences d'acides amines et sequences nucleotidiques et methodes d'utilisation de celles-ci pour le diagnostic
EP1954826A2 (fr) Nouvelles sequences de nucleotides et d'acides amines, ainsi que tests et procedes d'utilisation de ces sequences a des fins de diagnostic
CA2554707A1 (fr) Nouvelles sequences de nucleotides et d'acides amines; essais et methodes d'utilisation pour le diagnostic du cancer de a la prostate
CA2554585A1 (fr) Nouvelles sequences de nucleotides et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic de maladies cardiaques
CA2554623A1 (fr) Nouveaux nucleotides et sequences d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du colon
WO2005072053A2 (fr) Nouveaux nucleotides et sequences d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du colon

Legal Events

Date Code Title Description
FZDE Discontinued